, Tracking Stock Market Picks
Enter Symbol:
galena biopharma (GALE) [hlAlert]

up 4.00 %

galena biopharma (GALE) downgraded to Hold by Cantor Fitzgerald

Posted on: Tuesday,  Dec 8, 2015  10:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Hold galena biopharma (NASDAQ: GALE) on 12/08/2015. Previously Cantor Fitzgerald rated Buy galena biopharma (NASDAQ: GALE) on 06/04/2012.,
when the stock price was $1.50. Since then, galena biopharma has gained 4.00% as of 12/08/2015's recent price of $1.56.
If you would have followed the previous Cantor Fitzgerald's recommendation on GALE, you would have gained 4% of your investment in 1282 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/8/2015 10:25 AM Hold
as of 8/27/2015
1 Week down  -1.32 %
1 Month down  -23.19 %
3 Months up  9.55 %
1 YTD down  -69.95 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/4/2012 8:25 AM Buy
1.50 4.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy